(Q53292476)

13 May 2018

title

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides. (English)

1 reference

13 May 2018

1 reference

1 reference

3

Thomas C Südhof

1 reference

13 May 2018

Gilbert Gallardo

1

1 reference

13 May 2018

Oliver M Schlüter

series ordinal

2

1 reference

13 May 2018

language of work or name

English

0 references

publication date

24 February 2008

1 reference

13 May 2018

number of pages

8

0 references

published in

Nature Neuroscience

1 reference

13 May 2018

volume

11

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

301-308

1 reference

13 May 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

cites work

1 reference

7 January 2021

α-Synuclein in Lewy bodies

1 reference

7 January 2021

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

1 reference

7 January 2021

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

1 reference

7 January 2021

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

1 reference

7 January 2021

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

7 January 2021

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

1 reference

7 January 2021

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

7 January 2021

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

7 January 2021

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

7 January 2021

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

1 reference

7 January 2021

Alpha-synuclein and transgenic mouse models

1 reference

7 January 2021

Pathological proteins in Parkinson's disease: focus on the proteasome

1 reference

7 January 2021

Mechanisms and models of alpha-synuclein-related neurodegeneration.

1 reference

7 January 2021

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

1 reference

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

7 January 2021

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

1 reference

7 January 2021

Apolipoprotein E controls the risk and age at onset of Parkinson disease

1 reference

7 January 2021

Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families

1 reference

7 January 2021

Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia

1 reference

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

7 January 2021

Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.

1 reference

7 January 2021

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

1 reference

7 January 2021

Onset and progression in inherited ALS determined by motor neurons and microglia

1 reference

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

7 January 2021

Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration

1 reference

7 January 2021

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

1 reference

7 January 2021

Expression of apolipoprotein E during nerve degeneration and regeneration

1 reference

7 January 2021

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

1 reference

7 January 2021

Axonal transport defects: a common theme in neurodegenerative diseases

1 reference

7 January 2021

In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology

1 reference

7 January 2021

Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins.

1 reference

7 January 2021

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

1 reference

7 January 2021

Axon degeneration mechanisms: commonality amid diversity

1 reference

7 January 2021

Observations on the progress of Wallerian degeneration in transected peripheral nerves of C57BL/Wld mice in the presence of recruited macrophages

1 reference

7 January 2021

Proteasome dysfunction in aged human alpha-synuclein transgenic mice

1 reference

7 January 2021

Ubiquitination of alpha-synuclein.

1 reference

7 January 2021

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease

1 reference

7 January 2021

A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade

1 reference

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

1 reference

7 January 2021

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

1 reference

7 January 2021

Essential functions of synapsins I and II in synaptic vesicle regulation

1 reference

7 January 2021

Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity

1 reference

7 January 2021

Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN2058

1 reference

13 May 2018

1 reference

13 May 2018